Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol

B. FERNANDEZ-CAMINS, B. VLACHO, A. CANUDAS, M. ORTEGA, M. GRANADO-CASAS, A. PERERA-LLUNA, A. BOLUDA-SANSON, Y. EL-KHATTABI-OFKIR, J. FRANCH-NADAL and D. MAURICIO
BMJ Open. 2024 Dec 13; . doi:10.1136/bmjopen-2023-083825; PMID:39675821

• Any: 13/12/2024
• FI: 2.4
• Article

Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

M. ROJO-LÓPEZ, M. BERMÚDEZ-LÓPEZ, E. CASTRO, C. FARRÀS, G. TORRES, R. PAMPLONA, A. LECUBE, J. VALDIVIELSO, E. FERNÁNDEZ, J. JULVE, E. CASTELBLANCO, J. FRANCH-NADAL, N. ALONSO, M. GRANADO-CASAS and D. MAURICIO
ATHEROSCLEROSIS. 2023 Sep 1; . doi:10.1016/j.atherosclerosis.2023.117191; PMID:37586219

• Any: 01/09/2023
• FI: 4.9
• Article

Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project

E. SANCHEZ, M. SANCHEZ, C. LOPEZ-CANO, M. BERMUDEZ-LOPEZ, J. VALDIVIELSO, C. FARRAS-SALLES, R. PAMPLONA, G. TORRES, D. MAURICIO, E. CASTRO, E. FERNANDEZ and A. LECUBE
Nutrients. 2023 Jan 1; . doi:10.3390/nu15010203; PMID:36615860

• Any: 01/01/2023
• FI: 4.8
• Article

Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study

M. BERMUDEZ-LOPEZ, M. MARTI-ANTONIO, E. CASTRO-BOQUE, M. BRETONES, C. FARRAS, G. TORRES, R. PAMPLONA, A. LECUBE, D. MAURICIO, J. VALDIVIELSO and E. FERNANDEZ
Frontiers in Cardiovascular Medicine. 2022 Jul 14; . doi:10.3389/fcvm.2022.895917; PMID:35928938

• Any: 14/07/2022
• FI: 3.6
• Article

Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study

B. VLACHO, B. FERNANDEZ-CAMINS, A. CANUDAS-VENTURA, A. RODRÍGUEZ, A. MOLLO, F. CLARAMUNT, M. ANTENTAS, D. MAURICIO and J. FRANCH-NADAL
Journal of Clinical Medicine. 2024 Mar 1; . doi:10.3390/jcm13061544; PMID:38541770

• Any: 01/03/2024
• FI: 3
• Article